Question 1

What is the catalog number for Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)?

Accepted Answer

The catalog number for Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) is 50910116.

Question 2

What sizes are available for Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)?

Accepted Answer

Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) is available in the following size(s): 3x 1.0 µg.

Question 3

Is Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) in stock?

Accepted Answer

Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 5

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 6

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Zfp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Cdc20 (AR12), CF740 conjugate, 0.1mg/mL

Hepatocyte Specific (OCH1E5), CF594 conjugate, 0.1mg/mL

CD47 (B6H12.2), CF488A conjugate, 0.1mg/mL

Anti-DISC1 Antibody Picoband® (Biotine Conjugate)

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), 1mg/mL

RNF40 Recombinant Rabbit Monoclonal Antibody [JE46-30]